Abstract
Background: Costello syndrome is an ultra-rare RASopathy caused by gain-of-function mutations in the HRAS proto-oncogene, leading to constitutive activation of the RAS/MAPK signaling pathway and characterized by distinctive craniofacial features, multisystem involvement, and increased cancer risk. Case Presentation: We report a 37-week gestation male neonate with a prenatal diagnosis of severe polyhydramnios who presented at birth with coarse facies, macrocephaly, redundant skin, and severe multi-organ involvement initial chromosomal microarray analysis was normal (arr(X,Y)x1,(122)x2), but whole-exome sequencing identified a pathogenic heterozygous missense variant in the HRAS gene (c.34G >T p.Gly12Cys). Results: The clinical course was severe and progressive, with biventricular hypertrophic cardiomyopathy, complex arrhythmias, and prolonged dependence on mechanical ventilation, culminating in death at five months of age. Conclusions: This case highlights the diagnostic challenges associated with rare genetic disorders and underscores the importance of genomic sequencing as a fundamental diagnostic tool, while emphasizing genotypephenotype correlations and the need for strict oncological surveillance due to the increased risk of malignancies such as rhabdomyosarcoma.